Additional information
White Powder
1207630-52-1
ACI-090615
2-Butyl-3-2`-1-2`-(2H-tetrazol-5-yl)1,1`-biphenyl-4-ylmethyl-2H-tetrazol-5-yl1,1`-biphenyl-4-ylmethyl-1,3-diazaspiro4.4non-1-en-4-one
2-Butyl-3-[[2-[1-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-2H-tetrazol-5-yl][1,1-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
115.2-116.3°C
C39H38N10O
662.79
Ambient
2-8°C
1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-[2-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
Hypertension






![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)